Literature DB >> 25447455

Ethics in biomonitoring for occupational health.

M Manno1, F Sito2, L Licciardi2.   

Abstract

Biological monitoring, i.e., the use of biomarkers for the measurement of systemic human exposure, effects and susceptibility to chemicals has increased considerably in recent years. Biomonitoring techniques, originally limited to a few metals and other chemicals in the workplace, are currently applied to a large number of exposure situations and have become a useful tool for occupational and environmental health risk assessment. Almost any biomonitoring program, however, entails a number of relevant ethical issues, which concern all the phases of the entire process, from the selection of the biomarker to the study design, from the collection, storage and analysis of the biological sample to the interpretation, communication and management of the results, from the (truly?) informed consent of the worker to the independence and autonomy of the occupational health professional. These issues require a balanced assessment of the interests and responsibilities of all the parties, the worker primarily, but also the employer, the occupational health professional, the health authorities and, for research studies on new biomarkers, also the scientists involved. Ideally, decisions of ethical relevance concerning biomarkers should be based on, and respectful of the best scientific, legal and ethical evidence available. When, however, a conflict should arise, before any decision is taken a thorough risk-benefit analysis should be done, at the beginning of the process and after listening to the workers and the management involved, by the occupational physician or scientist, based on his/her professional experience, independent judgement and individual responsibility.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Biological monitoring; Ethics; Occupational health

Mesh:

Substances:

Year:  2014        PMID: 25447455     DOI: 10.1016/j.toxlet.2014.10.004

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  2 in total

Review 1.  Biomarkers of susceptibility: State of the art and implications for occupational exposure to engineered nanomaterials.

Authors:  Ivo Iavicoli; Veruscka Leso; Paul A Schulte
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-24       Impact factor: 4.219

2.  Guiding organisational decision-making about COVID-19 asymptomatic testing in workplaces: mixed-method study to inform an ethical framework.

Authors:  Jan W van der Scheer; Akbar Ansari; Meredith McLaughlin; Caitríona Cox; Kathleen Liddell; Jenni Burt; Jenny George; Rebecca Kenny; Ruth Cousens; Brandi Leach; James McGowan; Katherine Morley; Janet Willars; Mary Dixon-Woods
Journal:  BMC Public Health       Date:  2022-09-15       Impact factor: 4.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.